Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-10

Clinical Trial Update: Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining ursodeoxycholic acid for functional dyspepsia; the study is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Functional Dyspepsia | Phase 4 | Status: ACTIVE_NOT_RECRUITING